- Conditions
- Venous Leg Ulcer
- Interventions
- EscharEx (5% EX-02 formulation), Gel Vehicle, Non-surgical standard of care (NSSOC)
- Drug
- Lead sponsor
- MediWound Ltd
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 21
- States / cities
- Carlsbad, California • Fresno, California • Los Angeles, California + 17 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma
- Interventions
- EscharEx 5% (EX-02 formulation)
- Drug
- Lead sponsor
- MediWound Ltd
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 3
- States / cities
- Aventura, Florida • Brandon, Florida • Webster, Texas
- Conditions
- Venous Leg Ulcer, Diabetic Foot Ulcer
- Interventions
- EscharEx (EX-02 formulation)
- Drug
- Lead sponsor
- MediWound Ltd
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 3
- States / cities
- Tamarac, Florida • Las Vegas, Nevada • Chapel Hill, North Carolina